ETF Holdings Breakdown of NTLA

News associated with NTLA

SG Americas Securities LLC Sells 3,401 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)

SG Americas Securities LLC lessened its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 7.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 41,437 shares of the company’s stock after selling 3,401 shares during the quarter. SG Americas Securities LLC’s […] - 2025-06-27 07:21:01

Rhumbline Advisers Reduces Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Rhumbline Advisers trimmed its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 5.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 156,838 shares of the company’s stock after selling 9,410 shares during the quarter. Rhumbline Advisers’ holdings in […] - 2025-06-20 07:22:49

GAMMA Investing LLC Raises Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

GAMMA Investing LLC increased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 1,961.2% during the first quarter, Holdings Channel.com reports. The firm owned 7,544 shares of the company’s stock after acquiring an additional 7,178 shares during the quarter. GAMMA Investing LLC’s holdings in Intellia Therapeutics were worth $540,000 at the end of […] - 2025-06-19 07:08:57

Intellia Therapeutics (NASDAQ:NTLA) Earns Buy Rating from HC Wainwright

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $30.00 target price on the stock. HC Wainwright’s price target indicates a potential upside of 213.15% from the company’s current […] - 2025-06-18 05:22:53

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of “Moderate Buy” by Brokerages

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-one ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have issued a buy rating and one […] - 2025-06-04 07:52:47

Nuveen Asset Management LLC Sells 105,170 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Nuveen Asset Management LLC trimmed its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 28.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 260,697 shares of the company’s stock after selling 105,170 shares during the quarter. Nuveen Asset Management LLC’s […] - 2025-06-03 09:04:57

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 5.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 483,185 shares of the company’s […] - 2025-06-03 08:13:02

ProShare Advisors LLC Has $389,000 Stock Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

ProShare Advisors LLC grew its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 38.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 33,404 shares of the company’s stock after acquiring an additional 9,196 shares during the period. ProShare Advisors LLC’s holdings in Intellia Therapeutics were worth $389,000 at the end […] - 2025-05-29 08:04:57

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 15,888 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 7.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 227,255 shares of the company’s stock after buying an additional 15,888 shares during the period. MIRAE […] - 2025-05-21 08:40:53

BNP Paribas Financial Markets Has $5.11 Million Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

BNP Paribas Financial Markets increased its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 78.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 438,458 shares of the company’s stock after purchasing an additional 192,096 shares during […] - 2025-05-14 09:12:50

Guggenheim Cuts Intellia Therapeutics (NASDAQ:NTLA) Price Target to $45.00

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its price target cut by investment analysts at Guggenheim from $55.00 to $45.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Guggenheim’s price target indicates a potential upside of 440.87% from the stock’s previous close. […] - 2025-05-14 05:56:48

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives $36.47 Consensus Target Price from Brokerages

Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) have received an average recommendation of “Moderate Buy” from the twenty-one research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, thirteen have assigned a buy recommendation […] - 2025-05-13 05:44:49

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Stock Holdings Cut by Voya Investment Management LLC

Voya Investment Management LLC lessened its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 7.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 28,829 shares of the company’s stock after selling 2,213 shares during the period. Voya Investment Management LLC’s holdings in Intellia […] - 2025-05-12 08:26:58

Citigroup Cuts Intellia Therapeutics (NASDAQ:NTLA) Price Target to $10.00

Intellia Therapeutics (NASDAQ:NTLA – Free Report) had its price objective reduced by Citigroup from $14.00 to $10.00 in a research note released on Friday,Benzinga reports. They currently have a neutral rating on the stock. A number of other equities analysts have also commented on the stock. Wedbush restated a “neutral” rating and issued a $10.00 […] - 2025-05-12 07:26:47

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by Mariner LLC

Mariner LLC decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 14.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,820 shares of the company’s stock after selling 2,496 shares during the quarter. Mariner LLC’s holdings in Intellia Therapeutics were worth […] - 2025-05-08 07:38:44

Dimensional Fund Advisors LP Purchases 528,962 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Dimensional Fund Advisors LP increased its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 36.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,976,212 shares of the company’s stock after purchasing an additional 528,962 shares during the quarter. […] - 2025-05-07 08:26:54

MetLife Investment Management LLC Buys 3,491 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)

MetLife Investment Management LLC boosted its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 6.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,187 shares of the company’s stock after purchasing an additional 3,491 shares during the period. […] - 2025-05-05 08:22:56

Renaissance Technologies LLC Makes New $1.15 Million Investment in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Renaissance Technologies LLC acquired a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 98,700 shares of the company’s stock, valued at approximately $1,151,000. Several other institutional investors have also recently […] - 2025-04-30 08:40:57

Marshall Wace LLP Makes New Investment in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Marshall Wace LLP purchased a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 95,339 shares of the company’s stock, valued at approximately $1,112,000. Several other large investors also recently made […] - 2025-04-30 07:59:02

Barclays PLC Has $3.63 Million Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Barclays PLC boosted its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 6.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 311,632 shares of the company’s stock after buying an additional 18,837 shares during the period. Barclays PLC owned approximately 0.31% […] - 2025-04-29 08:19:03

Sterling Capital Management LLC Raises Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Sterling Capital Management LLC lifted its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 866.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,198 shares of the company’s stock after acquiring an additional 2,867 shares […] - 2025-04-25 08:34:52

Wells Fargo & Company MN Increases Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Wells Fargo & Company MN increased its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 38.3% in the fourth quarter, HoldingsChannel reports. The firm owned 277,692 shares of the company’s stock after buying an additional 76,872 shares during the period. Wells Fargo & Company MN’s holdings in Intellia Therapeutics were worth […] - 2025-04-23 07:34:49

XTX Topco Ltd Increases Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

XTX Topco Ltd grew its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 194.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,908 shares of the company’s stock after acquiring an additional 29,006 shares during the period. XTX Topco Ltd’s holdings in […] - 2025-04-21 09:10:48

Rockefeller Capital Management L.P. Increases Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Rockefeller Capital Management L.P. boosted its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 81.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 137,838 shares of the company’s stock after acquiring an additional 61,800 shares during the period. Rockefeller Capital Management L.P.’s holdings in Intellia […] - 2025-04-21 08:26:43

Schroder Investment Management Group Has $274,000 Stock Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Schroder Investment Management Group lessened its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 72.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,000 shares of the company’s stock after selling 61,999 shares during the quarter. Schroder Investment Management […] - 2025-04-09 08:12:51

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 67.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,293 shares of the company’s stock after acquiring an additional 6,972 shares during the quarter. Mitsubishi […] - 2025-04-04 08:12:58

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC lowered its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 22.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 15,639 shares of the company’s stock after selling 4,639 shares during the quarter. HighTower Advisors LLC’s holdings in Intellia Therapeutics were worth $182,000 at the end of the most recent […] - 2025-04-04 07:24:50

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Purchased by Intech Investment Management LLC

Intech Investment Management LLC increased its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 22.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 34,544 shares of the company’s stock after buying an additional 6,341 shares during the quarter. Intech […] - 2025-03-26 08:20:51

Amundi Trims Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Amundi decreased its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 19.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 48,795 shares of the company’s stock after selling 11,987 shares during the quarter. Amundi’s holdings in Intellia Therapeutics were worth $587,000 at the end of the most recent quarter. […] - 2025-03-21 07:53:05

Bank of New York Mellon Corp Cuts Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Bank of New York Mellon Corp reduced its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 284,614 shares of the company’s stock after selling 3,730 shares […] - 2025-03-20 07:13:00

NTLA institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	66,937	USD 643,265
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	49,125	USD 472,091
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	52,119	USD 500,864
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	52,119	USD 500,864
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	3,679	USD 35,355
Total =		223,979	USD 2,152,439

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer